N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide
CAS: 52869-18-8
Ref. 3D-CCA86918
50mg | To inquire | ||
100mg | To inquire |
Product Information
N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide is a medicinal compound that has shown promising results in the treatment of cancer. It acts as an inhibitor of cyclin-dependent kinases (CDKs), which are proteins that regulate cell cycle progression and are often overexpressed in cancer cells. This analog has been found to induce apoptosis (cell death) in human cancer cells and shows potential as an anticancer agent. Studies have shown that it can inhibit tumor growth in mice and has a favorable safety profile. N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide is excreted primarily through urine and may offer a new avenue for developing targeted cancer therapies.
Chemical properties
Technical inquiry about: 3D-CCA86918 N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.